Premium
Characterization of Gaddum's substance R
Author(s) -
Douglas G.J.,
Williams K.I.,
Flower R.J.
Publication year - 1991
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/j.1476-5381.1991.tb12278.x
Subject(s) - kallikrein , chemistry , substance p , endocrinology , kinin , ileum , medicine , methysergide , bradykinin , aprotinin , neuropeptide , biochemistry , enzyme , biology , antagonist , receptor
1 When the isolated small intestine of the rat is perfused via the mesenteric artery, an oxytocic principle (Gaddum's substance R) is released which is detectable in the perfusate after 30 min and is present in samples collected 8 h later. 2 The oxytocic activity of substance R is lost after boiling but is unaffected by treatment with thioglycolate. Furthermore, atropine, methysergide and indomethacin failed to antagonize uterine contractions to substance R. 3 Neither substance R nor urinary kallikrein alone induce a contraction of the guinea‐pig isolated ileum. However, in the presence of kininogen both substance R and urinary kallikrein produce a slow and prolonged contraction of the guinea‐pig ileum. 4 The oxytocic and kininogenase properties of both substance R and urinary kallikrein are inhibited by Trasylol. 5 Soy bean trypsin inhibitor (SBTI) selectively inhibited both the oxytocic and the kininogenase activities of substance R but not those of urinary kallikrein. 6 Gel filtration of substance R resolved a single peak of oxytocic activity with an estimated molecular weight of 40 kDa. 7 We conclude that substance R is a kininogenase enzyme which may be distinguished from plasma kallikrein by its molecular weight and from urinary kallikrein by its susceptibility to SBTI. The exact nature of this enzyme remains to be elucidated.